Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Gastroenterologie Clinique Et Biologique
|
March 28, 2006
Subsequent resection of locally advanced pancreatic carcinoma after chemoradiotherapy
Xavier Adhoute, Denis Smith, Véronique Vendrely, et al.
Diagnostics (Basel, Switzerland)
|
April 13, 2023
Radiomics, a Promising New Discipline: Example of Hepatocellular Carcinoma
Thomas Lévi-Strauss, Bettina Tortorici, Olivier Lopez, et al.
European Journal of Gastroenterology & Hepatology
|
July 31, 2024
Outcomes and safety of atezolizumab plus bevacizumab in the treatment of hepatocellular carcinoma: treatment prognosis and comparison with tyrosine kinase inhibitors in a French multicenter matched real-life study
Xavier Adhoute, Alexia Gonzalez, Thomas Levi-Strauss, et al.
European Journal of Gastroenterology & Hepatology
|
February 1, 2018
Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case-control study
Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Biomedicines
|
May 27, 2026
Hepatocellular Carcinoma Treatment with Immune Checkpoint Inhibitors: RECA and CRAFITY Scores Reveal Distinct Clinical Courses and Highlight the Role of Systemic Inflammation in Prognosis
Xavier Adhoute, Constance Chailloux, Feng Xia, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 13, 2015
Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis
Julien Edeline, Laurence Crouzet, Boris Campillo-Gimenez, et al.
World Journal of Clinical Cases
|
July 5, 2021
Expected outcomes and patients' selection before chemoembolization-"Six-and-Twelve or Pre-TACE-Predict" scores may help clinicians: Real-life French cohorts results
Xavier Adhoute, Edouard Larrey, Rodolphe Anty, et al.
Journal of Hepatology
|
December 3, 2014
Retreatment with TACE: the ABCR SCORE, an aid to the decision-making process
Xavier Adhoute, Guillaume Penaranda, Sebastien Naude, et al.
World Journal of Gastrointestinal Oncology
|
September 26, 2022
Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching
Xavier Adhoute, Marie De Matharel, Laurent Mineur, et al.
European Journal of Gastroenterology & Hepatology
|
May 3, 2019
Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort
Xavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Gastroenterologie Clinique Et Biologique
|
March 28, 2006
Subsequent resection of locally advanced pancreatic carcinoma after chemoradiotherapy
Xavier Adhoute, Denis Smith, Véronique Vendrely, et al.
Diagnostics (Basel, Switzerland)
|
April 13, 2023
Radiomics, a Promising New Discipline: Example of Hepatocellular Carcinoma
Thomas Lévi-Strauss, Bettina Tortorici, Olivier Lopez, et al.
European Journal of Gastroenterology & Hepatology
|
July 31, 2024
Outcomes and safety of atezolizumab plus bevacizumab in the treatment of hepatocellular carcinoma: treatment prognosis and comparison with tyrosine kinase inhibitors in a French multicenter matched real-life study
Xavier Adhoute, Alexia Gonzalez, Thomas Levi-Strauss, et al.
European Journal of Gastroenterology & Hepatology
|
February 1, 2018
Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case-control study
Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Biomedicines
|
May 27, 2026
Hepatocellular Carcinoma Treatment with Immune Checkpoint Inhibitors: RECA and CRAFITY Scores Reveal Distinct Clinical Courses and Highlight the Role of Systemic Inflammation in Prognosis
Xavier Adhoute, Constance Chailloux, Feng Xia, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 13, 2015
Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis
Julien Edeline, Laurence Crouzet, Boris Campillo-Gimenez, et al.
World Journal of Clinical Cases
|
July 5, 2021
Expected outcomes and patients' selection before chemoembolization-"Six-and-Twelve or Pre-TACE-Predict" scores may help clinicians: Real-life French cohorts results
Xavier Adhoute, Edouard Larrey, Rodolphe Anty, et al.
Journal of Hepatology
|
December 3, 2014
Retreatment with TACE: the ABCR SCORE, an aid to the decision-making process
Xavier Adhoute, Guillaume Penaranda, Sebastien Naude, et al.
World Journal of Gastrointestinal Oncology
|
September 26, 2022
Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching
Xavier Adhoute, Marie De Matharel, Laurent Mineur, et al.
European Journal of Gastroenterology & Hepatology
|
May 3, 2019
Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort
Xavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, et al.
Page
of 7